menu search

BICX / BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th
Anaheim, California--(Newsfile Corp. - March 2, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that management will present at the Q1 Investor Summit, hosted by the Investor Summit Group, being held virtually on March 8-9, 2022.Lourdes Felix, Chief Executive Officer, Chief Financial Officer, and Director of BioCorRx Inc., and Brady Granier, President, Director and CEO of BioCorRx Pharmaceuticals, are... Read More
Posted: Mar 2 2022, 08:30
Author Name: Newsfile Corp
Views: 102160

BICX News  

BioCorRx to Present at Sequire Biotechnology Conference on February 2nd

By GlobeNewsWire
January 27, 2023

BioCorRx to Present at the LD Micro Invitational XII on June 7th

By GlobeNewsWire
May 31, 2022

BioCorRx to Present at the LD Micro Invitational XII on June 7th

ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --  BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of inn more_horizontal

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

By Newsfile Corp
March 2, 2022

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

Anaheim, California--(Newsfile Corp. - March 2, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment more_horizontal

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

By Newsfile Corp
March 2, 2022

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

Anaheim, California--(Newsfile Corp. - March 2, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment more_horizontal

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

By Newsfile Corp
March 2, 2022

BioCorRx to Present at the Q1 Investor Summit Conference on March 9th

Anaheim, California--(Newsfile Corp. - March 2, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment more_horizontal


Search within

Pages Search Results: